Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/50098
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Naranjo, A. | en_US |
dc.contributor.author | Ojeda-Bruno, S. | en_US |
dc.contributor.author | Bilbao-Cantarero, A. | en_US |
dc.contributor.author | Quevedo-Abeledo, J. C. | en_US |
dc.contributor.author | Diaz-González, B. V. | en_US |
dc.contributor.author | Rodríguez-Lozano, C. | en_US |
dc.contributor.other | Naranjo Hernandez, Antonio | - |
dc.date.accessioned | 2018-11-24T13:16:57Z | - |
dc.date.available | 2018-11-24T13:16:57Z | - |
dc.date.issued | 2015 | en_US |
dc.identifier.issn | 0937-941X | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/50098 | - |
dc.description.abstract | A fracture liaison service in Spain is able to maintain 73 % of the patients on antiresorptive 2 years after the fracture.Introduction The purpose of this study was to evaluate the 2-year effectiveness of a program for the secondary prevention of fractures.Methods Fragility fractures in patients over 50 attending the emergency room in our centre are captured by the recruitment system of a secondary prevention program. The unit is attended by a nurse, coordinated by two rheumatologists and with the collaboration of primary care consisted of a training program and annual meetings. The outcome of the program was analysed 2 years after implementation, including: (1) percentage of attendees/eligible; (2) percentage of attendees who start treatment with antiresorptive; (3) percentage of patients who retain treatment after 6, 12, 18 and 24 months; and (4) factors associated to adherence.Results After 2 years of implementation, the program detected 1674 patients with fracture, of whom 759 finally entered the program (57 % of eligible). After 3 months, 82 % of patients prescribed an antiresorptive started treatment. After a year, 52 % of the patients in the program, 72 % of those of a prescribed treatment, were taking antiresorptives. Adherence at 24 months among those who had prescribed anti-fracture drugs was 73 %. Factors associated with adherence at 12 months were female sex (76 vs 45 %; p = 0.01) and previous treatment with antiresorptive (86 vs 68 %; p = 0.02).Conclusions In Spain, a program designed to prevent secondary fragility fractures based on the collaboration between primary care and rheumatology seems effective in terms of recruitment of patients and adherence to treatment in the mid/long-term. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Osteoporosis International | en_US |
dc.source | Osteoporosis International[ISSN 0937-941X],v. 26 (11), p. 2579-2585 | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject.other | Secondary Prevention | en_US |
dc.subject.other | Osteoporotic Fractures | en_US |
dc.subject.other | Fragility Fractures | en_US |
dc.subject.other | Hip Fracture | en_US |
dc.subject.other | Initiation | en_US |
dc.subject.other | Hospitals | en_US |
dc.subject.other | Program | en_US |
dc.subject.other | Risk | en_US |
dc.subject.other | Care | en_US |
dc.title | Two-year adherence to treatment and associated factors in a fracture liaison service in Spain | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1007/s00198-015-3185-z | en_US |
dc.identifier.scopus | 84944355498 | - |
dc.identifier.isi | 000363042000004 | - |
dcterms.isPartOf | Osteoporosis International | - |
dcterms.source | Osteoporosis International[ISSN 0937-941X],v. 26 (11), p. 2579-2585 | - |
dc.contributor.authorscopusid | 7003297397 | - |
dc.contributor.authorscopusid | 6602428868 | - |
dc.contributor.authorscopusid | 7801311085 | - |
dc.contributor.authorscopusid | 55295814500 | - |
dc.contributor.authorscopusid | 56671406700 | - |
dc.contributor.authorscopusid | 6603136298 | - |
dc.description.lastpage | 2585 | en_US |
dc.description.firstpage | 2579 | en_US |
dc.relation.volume | 26 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.identifier.wos | WOS:000363042000004 | - |
dc.contributor.daisngid | 32393321 | - |
dc.contributor.daisngid | 550893 | - |
dc.contributor.daisngid | 4801071 | - |
dc.contributor.daisngid | 11153510 | - |
dc.contributor.daisngid | 13419208 | - |
dc.contributor.daisngid | 11274011 | - |
dc.contributor.daisngid | 1048977 | - |
dc.identifier.investigatorRID | E-7910-2010 | - |
dc.description.numberofpages | 7 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Naranjo, A | - |
dc.contributor.wosstandard | WOS:Ojeda-Bruno, S | - |
dc.contributor.wosstandard | WOS:Bilbao-Cantarero, A | - |
dc.contributor.wosstandard | WOS:Quevedo-Abeledo, JC | - |
dc.contributor.wosstandard | WOS:Diaz-Gonzalez, BV | - |
dc.contributor.wosstandard | WOS:Rodriguez-Lozano, C | - |
dc.date.coverdate | Noviembre 2015 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 1,48 | - |
dc.description.jcr | 3,445 | - |
dc.description.sjrq | Q1 | - |
dc.description.jcrq | Q2 | - |
dc.description.scie | SCIE | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Grupo de investigaciones infecciosas, nutricionales e inflamatorias en pacientes hospitalarios / Study Group on infectious, nutritional and inflammatory diseases in hospitalized patients | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Médicas y Quirúrgicas | - |
crisitem.author.orcid | 0000-0002-2013-6664 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Naranjo Hernández, Antonio | - |
Colección: | Artículos |
Citas SCOPUSTM
28
actualizado el 10-nov-2024
Citas de WEB OF SCIENCETM
Citations
28
actualizado el 10-nov-2024
Visitas
71
actualizado el 16-nov-2024
Google ScholarTM
Verifica
Altmetric
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.